“…A considerable number of clinically used drugs such as minoxidil, phenobarbital, primidone, zidovudine, stavudine, 5-flurouracil, methotrexate, imatinib, dasatinib, pazopanib, nilotinib, cytarabine, uramustine, tegafur, risperidone, sulfamethazine and trimethoprim contain the pyrimidine heterocyclic scaffold [ 14 , 15 ]. In recent years, diverse biological activities of pyrimidine derivatives, including anticancer [ 16 , 17 ], antibacterial [ 18 , 19 , 20 ], antifungal [ 21 ], antitubercular [ 21 , 22 ], antimalarial [ 23 ], antiviral [ 24 , 25 , 26 ], analgesic [ 27 ], antioxidant [ 28 , 29 ], anti-lipoxygenase [ 30 , 31 ] and anti-inflammatory activities have been reported [ 32 , 33 ]. Thus, the pyrimidine ring can be considered as a promising pharmacophoric scaffold for the synthesis of novel bioactive molecules for the treatment of various diseases.…”